Latest filing published 05 Feb 2021 for Motus GI Holdings, Inc., €46k.
First 200 filings with a declared amount
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Larry N. Feinberg is a declared insider at 8 companies; the most frequent names are Hansen Medical Inc, Accelerate Diagnostics, Inc and Biolase, Inc. The record holds 289 filings, for trades running from 1 February 2005 to 26 January 2021.
In open-market terms, that means 196 purchases worth €67.2M on one side and 50 sales worth €13.4M on the other. The amount is not disclosed for 3 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 24 share grants. In 2021 alone, the filings show no purchases and 2 sales.
The median purchase comes to €39k. Clusters matter here: 4 out of 24 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 7 purchases show a median change of -14.0%, with the price up in 29% of them. They describe history only and say nothing certain about the share price ahead.
On 5 February 2021 came the latest disclosure, an open-market sale for €46k in Motus GI Holdings, Inc. The most recent open-market purchase was published on 31 October 2019, 2,553 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 283 declarations